| NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 00555-0904-05 | 00555-0904 | Tamoxifen Citrate | Tamoxifen Citrate | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Feb 20, 2003 | Nov 30, 2011 | No Longer Used | ||
| 51655-0860-26 | 51655-0860 | ESTRADIOL | ESTRADIOL | 0.5 mg/1 | Hormonal Therapy | Estrogen | Oral | May 4, 2023 | In Use | ||
| 00591-0487-05 | 00591-0487 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Mar 14, 1996 | Jun 30, 2018 | In Use | |
| 76346-0550-03 | 76346-0550 | Relacorilant | Lifyorli | 25.0 mg/1, 100.0 mg/1 | Chemotherapy | Glucocorticoid Receptor (GR) Antagonist | Oral | Mar 25, 2026 | In Use | ||
| 00185-7400-14 | 00185-7400 | Leuprolide Acetate | Leuprolide Acetate | 1.0 mg/.2mL | Hormonal Therapy | GnRH Agonist | Subcutaneous | Jan 6, 2011 | In Use | ||
| 00074-3473-55 | 00074-3473 | Leuprolide Acetate | Lupron Depot | 45.0 mg/1.5mL | Hormonal Therapy | GnRH Agonist | Intramuscular | Mar 15, 2026 | In Use | ||
| 00378-9040-05 | 00378-9040 | Cysteamine bitartrate | Cystagon | 50.0 mg/1 | Chemotherapy | Cystine-Depleting Agent | Oral | Apr 11, 2005 | In Use | ||
| 49999-0083-30 | 49999-0083 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Mar 12, 2012 | Nov 18, 2016 | No Longer Used | |
| 00378-9045-05 | 00378-9045 | Cysteamine bitartrate | Cystagon | 150.0 mg/1 | Chemotherapy | Cystine-Depleting Agent | Oral | Apr 11, 2005 | In Use | ||
| 68462-0897-10 | 68462-0897 | Octreotide Acetate | Octreotide Acetate | 500.0 ug/mL | Hormonal Therapy | Somatostatin Analog | Intravenous, Subcutaneous | Aug 9, 2023 | In Use | ||
| 83831-0159-02 | 83831-0159 | Fulvestrant | CLIGAVYX | 250.0 mg/5mL | Hormonal Therapy | Estrogen Receptor Antagonist | Intramuscular | Jul 1, 2026 | In Use | ||
| 16729-0035-17 | 16729-0035 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Apr 15, 2018 | In Use | ||
| 68071-3394-02 | 68071-3394 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Jul 12, 2017 | In Use | ||
| 23155-0014-05 | 23155-0014 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Nov 5, 2010 | Sep 23, 2019 | In Use | |
| 54868-2985-03 | 54868-2985 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 5.0 mg/1 | Hormonal Therapy | Progestin | Oral | Sep 19, 1995 | In Use | ||
| 85043-0025-02 | 85043-0025 | Leuprolide acetate | Vabrinty | 22.5 mg/.375mL | Hormonal Therapy | GnRH Agonist | Subcutaneous | Aug 4, 2025 | In Use | ||
| 55289-0603-21 | 55289-0603 | Estradiol | Estradiol | 0.5 mg/1 | Hormonal Therapy | Estrogen | Oral | Dec 23, 2009 | Nov 23, 2021 | No Longer Used | |
| 23155-0685-31 | 23155-0685 | Octreotide Acetate | Octreotide Acetate | 200.0 ug/mL | Hormonal Therapy | Somatostatin Analog | Intravenous, Subcutaneous | May 25, 2022 | In Use | ||
| 70934-0798-30 | 70934-0798 | Estradiol | Estradiol | 0.5 mg/1 | Hormonal Therapy | Estrogen | Oral | Oct 19, 2020 | In Use | ||
| 55513-0025-01 | 55513-0025 | Darbepoetin alfa | Aranesp | 100.0 ug/.5mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Feb 18, 2011 | In Use | ||
| 43063-0706-30 | 43063-0706 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Oct 6, 2016 | Oct 31, 2023 | No Longer Used | |
| 68001-0484-85 | 68001-0484 | Fulvestrant | Fulvestrant | 250.0 mg/5mL | Hormonal Therapy | Estrogen Receptor Antagonist | Intramuscular | Mar 1, 2021 | In Use | ||
| 50090-5812-00 | 50090-5812 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Oct 18, 2021 | In Use | ||
| 55513-0043-04 | 55513-0043 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Jun 1, 2004 | Dec 31, 2008 | No Longer Used | |||
| 55513-0010-01 | 55513-0010 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Oct 1, 2001 | Mar 31, 2009 | No Longer Used |
Found 12482 results — Export these results
Home